VOYAGER THERAPEUTICS INC's ticker is VYGR and the CUSIP is 92915B106. A total of 113 filers reported holding VOYAGER THERAPEUTICS INC in Q2 2020. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $640,000 | +68.9% | 60,000 | +100.0% | 0.21% | -6.6% |
| Q2 2020 | $379,000 | +38.3% | 30,000 | 0.0% | 0.23% | -5.8% |
| Q1 2020 | $274,000 | -34.6% | 30,000 | 0.0% | 0.24% | -20.3% |
| Q4 2019 | $419,000 | -18.8% | 30,000 | 0.0% | 0.30% | -11.3% |
| Q3 2019 | $516,000 | -36.8% | 30,000 | 0.0% | 0.34% | -30.8% |
| Q2 2019 | $817,000 | +42.3% | 30,000 | 0.0% | 0.50% | +38.1% |
| Q1 2019 | $574,000 | +85.2% | 30,000 | -9.1% | 0.36% | +22.9% |
| Q4 2018 | $310,000 | -50.3% | 33,000 | 0.0% | 0.29% | -27.3% |
| Q3 2018 | $624,000 | -3.3% | 33,000 | 0.0% | 0.40% | -8.0% |
| Q2 2018 | $645,000 | +4.0% | 33,000 | 0.0% | 0.44% | +7.4% |
| Q1 2018 | $620,000 | -13.2% | 33,000 | -23.3% | 0.41% | -2.6% |
| Q4 2017 | $714,000 | +44.5% | 43,000 | +79.2% | 0.42% | +64.3% |
| Q3 2017 | $494,000 | – | 24,000 | – | 0.26% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TRV GP III, LLC | 6,391,176 | $60,077,000 | 50.34% |
| ARMISTICE CAPITAL, LLC | 2,836,000 | $26,658,000 | 2.02% |
| Casdin Capital, LLC | 1,128,075 | $10,604,000 | 1.81% |
| BB BIOTECH AG | 2,865,841 | $26,939,000 | 0.86% |
| HIGHLINE CAPITAL MANAGEMENT, L.P. | 1,284,697 | $12,076,000 | 0.81% |
| Aevitas Wealth Management, Inc. | 48,300 | $454,000 | 0.46% |
| GREAT POINT PARTNERS LLC | 365,132 | $3,432,000 | 0.43% |
| Patriot Financial Group Insurance Agency, LLC | 61,320 | $576,000 | 0.38% |
| HARBOURVEST PARTNERS LLC | 72,726 | $684,000 | 0.32% |
| Birchview Capital, LP | 33,000 | $310,000 | 0.29% |